The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease. This story matters for General News readers tracking general. Reported by nytimes.com. Read the full original at the source link below.
Originally reported by nytimes.com. NewsDebate curates and briefs the general news stories that matter. Our editorial policy →